Source: International Congress 2017 – Rational strategies for specific treatment situations in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Paul E. Van Schil (Edegem (Antwerp), Belgium). Stage I NSCLC: the extent of surgical resection needed, or, better yet, radiotherapy?. International Congress 2017 – Rational strategies for specific treatment situations in lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Locally advanced disease – indications and results of extended resections Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005 Prerequisites, potential and limits of thoracic surgery with curative intent for stage III NSCLC Source: International Congress 2019 – Locally advanced non-small cell lung cancer in 2019: novel diagnostic and therapeutic strategies to tackle complex stage III disease Year: 2019 Respective indications of chemotherapy, radiotherapy and surgery in limited disease stage small cell lung carcinoma Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020 Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too! Source: Eur Respir J 2016; 48: 276-278 Year: 2016 Radiotherapy and chemotherapy for elderly patients with stage I–II unresected lung cancer}, Source: Eur Respir J 2012; 40: 957-964 Year: 2012 Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Long time survival after resection for multiple primary lung cancers. A population-based study Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009 Impact of neoadjuvant therapies on surgical indications and early postoperative outcome Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Is there any survival benefit of surgery after neoadjuvant chemoradiotherapy and persisting pn2/3 in stage III NSCLC? Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009 Adjuvant chemotherapy uptake and survival of patients with NSCLC after complete resection:  Single institution/single area experience. Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Treatment of early (stage I/II) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005 Will stereotactic body radiotherapy prolong survival in patients with stage IV NSCLC? Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Source: Eur Respir J 2002; 19: 464-468 Year: 2002 Sublobar resections vs lobectomy for early stage lung cancer: where do we stand? Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process? Year: 2020